Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy ; volume:37 ; number:1 ; day:26 ; month:12 ; year:2022 ; pages:21-33 ; date:1.2023
BioDrugs ; 37, Heft 1 (26.12.2022), 21-33, 1.2023
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-022-00573-3
- URN
-
urn:nbn:de:101:1-2023032121105486471177
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Müller, Dafne
- SpringerLink (Online service)
Ähnliche Objekte (12)
IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands for cancer immunotherapy
Do inhibitory receptors need to be proximal to stimulatory receptors to function?
Co-stimulatory agonists: An insight into the immunotherapy of cancer
An orphan viral TNF receptor superfamily member identified in lymphocystis disease virus
Quantitative contributions of TNF receptor superfamily members to CD8 + T‐cell responses
Anti-TNF, a magic bullet in cancer immunotherapy?
A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members
Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling
Immunotherapies targeting stimulatory pathways and beyond
Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
Targeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network
IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands for cancer immunotherapy
Do inhibitory receptors need to be proximal to stimulatory receptors to function?
Co-stimulatory agonists: An insight into the immunotherapy of cancer
An orphan viral TNF receptor superfamily member identified in lymphocystis disease virus
Quantitative contributions of TNF receptor superfamily members to CD8 + T‐cell responses
Anti-TNF, a magic bullet in cancer immunotherapy?
A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members
Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling
Immunotherapies targeting stimulatory pathways and beyond
Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
Targeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network
IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands for cancer immunotherapy
Do inhibitory receptors need to be proximal to stimulatory receptors to function?
Co-stimulatory agonists: An insight into the immunotherapy of cancer
An orphan viral TNF receptor superfamily member identified in lymphocystis disease virus
Quantitative contributions of TNF receptor superfamily members to CD8 + T‐cell responses
Anti-TNF, a magic bullet in cancer immunotherapy?
A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members
Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling
Immunotherapies targeting stimulatory pathways and beyond
Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily